Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 8

The search for common pathways underlying asthma and COPD

Authors Kaneko Y, Yatagai Y, Yamada H, Iijima H, Masuko H, Sakamoto T, Hizawa N

Received 26 October 2012

Accepted for publication 8 December 2012

Published 25 January 2013 Volume 2013:8 Pages 65—78


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Yoshiko Kaneko, Yohei Yatagai, Hideyasu Yamada, Hiroki Iijima, Hironori Masuko, Tohru Sakamoto, Nobuyuki Hizawa

Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

Abstract: Recently, several genes and genetic loci associated with both asthma and chronic obstructive pulmonary disease (COPD) have been described as common susceptibility factors for the two diseases. In complex diseases such as asthma and COPD, a large number of molecular and cellular components may interact through complex networks involving gene–gene and gene–environment interactions. We sought to understand the functional and regulatory pathways that play central roles in the pathobiology of asthma and COPD and to understand the overlap between these pathways. We searched the PubMed database up to September 2012 to identify genes found to be associated with asthma, COPD, tuberculosis, or essential hypertension in at least two independent reports of candidate-gene associations or in genome-wide studies. To learn how the identified genes interact with each other and other cellular proteins, we conducted pathway-based analysis using Ingenuity Pathway Analysis software. We identified 108 genes and 58 genes that were significantly associated with asthma and COPD in at least two independent studies, respectively. These susceptibility genes were grouped into networks based on functional annotation: 12 (for asthma) and eleven (for COPD) networks were identified. Analysis of the networks for overlap between the two diseases revealed that the networks form a single complex network with 229 overlapping molecules. These overlapping molecules are significantly involved in canonical pathways including the “aryl hydrocarbon receptor signaling,” “role of cytokines in mediating communication between immune cells,” “glucocorticoid receptor signaling,” and “IL-12 signaling and production in macrophages” pathways. The Jaccard similarity index for the comparison between asthma and COPD was 0.81 for the network-level comparison, and the odds ratio was 3.62 (P < 0.0001) for the asthma/COPD pair in comparison with the tuberculosis/ essential hypertension pair. In conclusion, although the identification of asthma and COPD networks is still far from complete, these networks may be used as frameworks for integrating other genome-scale information including expression profiling and phenotypic analysis. Network overlap between asthma and COPD may indicate significant overlap between the pathobiology of these two diseases, which are thought to be genetically related.

Keywords: COPD, asthma, network, common pathways, aryl hydrocarbon receptor signaling

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Readers of this article also read:

Shared decision-making in the People’s Republic of China: current status and future directions

Huang RC, Gionfriddo MR, Zhang LZ, Leppin AL, Ting HH, Montori VM

Patient Preference and Adherence 2015, 9:1129-1141

Published Date: 6 August 2015

The association between chronic pain and obesity

Okifuji A, Hare BD

Journal of Pain Research 2015, 8:399-408

Published Date: 14 July 2015

Impact of noncommunicable diseases in the State of Qatar

Al-Kaabi SK, Atherton A

ClinicoEconomics and Outcomes Research 2015, 7:377-385

Published Date: 2 July 2015

Risk factors for chronic obstructive pulmonary disease among never-smokers in Korea

Lee SJ, Kim SW, Kong KA, Ryu YJ, Lee JH, Chang JH

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:497-506

Published Date: 5 March 2015

Oxidative stress and antibacterial properties of a graphene oxide-cystamine nanohybrid

Nanda SS, An SS, Yi DK

International Journal of Nanomedicine 2015, 10:549-556

Published Date: 12 January 2015

Generalized in vitro-in vivo relationship (IVIVR) model based on artificial neural networks

Mendyk A, Tuszyński PK, Polak S, Jachowicz R

Drug Design, Development and Therapy 2013, 7:223-232

Published Date: 27 March 2013

Correcting magnesium deficiencies may prolong life

Rowe WJ

Clinical Interventions in Aging 2012, 7:51-54

Published Date: 16 February 2012

Asthma, chronic obstructive pulmonary disease, or both? Diagnostic labeling and spirometry in primary care patients aged 40 years or more

Melbye H, Drivenes E, Dalbak LG, Leinan T, Høegh-Henrichsen S, Østrem A

International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:597-603

Published Date: 17 November 2011

Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment

Tang J, Xu N, Ji H, Liu H, Wang Z, Wu L

International Journal of Nanomedicine 2011, 6:2429-2435

Published Date: 19 October 2011

Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel

Andrew S Bomback, James A Tumlin, Joel Baranski, et al

Drug Design, Development and Therapy 2011, 5:147-153

Published Date: 14 March 2011